Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01121783
Other study ID # Lactisole
Secondary ID
Status Recruiting
Phase N/A
First received May 10, 2010
Last updated May 10, 2010
Start date May 2010
Est. completion date May 2011

Study information

Verified date March 2010
Source Salford Royal NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority United Kingdom: National Health Service (NHS)
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine whether the sweet taste receptors in the gut are involved in sensing sweet substances and controlling appetite and the amount we eat. Lactisole is a substance commonly used in food products to reduce the perceived sweetness of certain sugars and sweeteners. The aim of this study is to investigate whether the responses to a glucose solution, intragastrically administered to healthy male and female volunteers, is affected by the presence of lactisole in the gut. Understanding the mechanisms by which nutrients are initially detected in the gut and how they influence food intake is critical to the development of novel food products that could reduce food consumption.


Description:

Obesity is epidemically prevalent and a major risk factor for chronic diseases making it fundamental to understand the pathways controlling food intake. During the course of a meal and afterwards the gut and brain communicate to control how full the eater feels and thus control the amount of food eaten. The information relayed from the gut to the brain regarding ingested nutrients is of increasing importance and understanding the mechanisms by which nutrient molecules are initially detected in the gut and how they signal to the brain to influence food intake is critical to the development of novel food products that could induce fullness and reduce food consumption. Increasing our understanding of how nutrients are sensed in the gut and how this may influence subsequent food intake provides promising targets for obesity prevention and treatment. Recent discoveries have shown that sweet taste receptors similar to those located in the tongue are present in the gut. It is suggested that theses receptors are involved in the way nutrients are sensed and may play an important role in appetite control and food intake.


Recruitment information / eligibility

Status Recruiting
Enrollment 24
Est. completion date May 2011
Est. primary completion date May 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Aged between 18-45 years

- BMI between 18-25kg/m2

- General good health

Exclusion Criteria:

- Underweight or Overweight (Body Mass Index <19 or >25 kg.m-2)

- Females who are pregnant or breastfeeding

- Currently taking medication (except females taking oral contraceptive)

- Smokers

- Currently dieting or have experienced a weight change +/- 3kg in past 6 months

- Metabolic disorders (eg. Type 2 diabetes)

- History of gastrointestinal disorders

- Participation in other research in past 3 months

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
Lactisole
A pre-infusion of lactisole solution (0.25mg/ml) is administered as a bolus (1ml/kg bodyweight)via intragastric tube. After 15 minutes a 1M glucose solution is administered as a bolus via intragastric tube.
Dietary Supplement:
Lactisole
A pre-infusion of lactisole solution (0.25mg/ml)is administered as a bolus (1ml/kg body weight) via intragastric tube. After 15 minutes tap water will be administered as a bolus via the intragastric tube.
Lactisole
A pre-infusion of tap water(is administered as a bolus (1ml/kg bodyweight)via intragastric tube. After 15 minutes a 1M glucose solution is administered as a bolus via intragastric tube.
Lactisole
A pre-infusion of tap water is administered as a bolus (1ml/kg bodyweight)via intragastric tube. After 15 minutes tap water is administered as a bolus via intragastric tube.

Locations

Country Name City State
United Kingdom Salford Royal NHS Foundation Trust Manchester

Sponsors (2)

Lead Sponsor Collaborator
Salford Royal NHS Foundation Trust University of Manchester

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood glucose Blood samples will be collected at baseline and 5, 15 and 30 minute intervals until 150 minutes after the glucose infusion No
Secondary Subjective appetite ratings Participants will be asked to complete visual analogue scale questionnaire (VAS) up to a total of 6 times for the duration of each study 30 minute intervals No
Secondary Gastric emptying rate In order to assess gastric emptying, a stable isotope of carbon, in the form of 13Csodium acetate will be added to the test meal. This is absorbed only once it has passed through the stomach into the duodenum. It is then metabolised and exhaled in the breath as 13Clabelled carbon dioxide (CO2) where it can be measured. Breath samples are collected at 5, 15 and 30 minute intervals up to a total of 10 times until 150 minutes No
Secondary Energy intake Energy intake will be assessed by an ad libitum test meal provided at the end of each study and food diaries completed for the remainder of the day No
Secondary Gut hormones Blood samples will be processed to examine hormone levels of GLP-1, PYY, and insulin. Blood samples will be collected at baseline, 5, 15 and 30 minute intervals until 150 minutes after glucose infusion. No
See also
  Status Clinical Trial Phase
Recruiting NCT04578067 - Empowering Immigrant Women for Active and Healthy Lifestyle N/A
Completed NCT04256746 - Dose Response Study of a Natural Extract for Reducing Post Prandial Blood Glucose N/A
Completed NCT03254082 - Glycemic Response of Sorghum N/A
Completed NCT02536066 - Daily Physical Activity After Meals -Long Term Effects on Blood Glucose N/A
Completed NCT00444171 - Glucose Control by eMPC Algorithm in Peri- and Postoperative Period in Cardiac Surgery Patients N/A
Completed NCT00302302 - The Effects of L-arabinose on Intestinal Sucrase Activity in Man Phase 1
Completed NCT04378374 - The Effect of Pulse Flours on Blood Glucose, Satiety and Food Intake N/A
Completed NCT04451655 - Glycemic Stability During the Intraoperative Period Among Patients With DM Undergoing CABG Surgery N/A
Recruiting NCT04989712 - MOReS Freestyle Libre Validation Study N/A
Completed NCT05352724 - Clinical Trial to Evaluate the Efficacy of a Sport Drink After High-intensity Aerobic Exercise N/A
Completed NCT04260425 - A Pilot Study Evaluating Oat Polyphenols on Post-prandial Glucose Response N/A
Completed NCT04258501 - Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response N/A
Completed NCT02968498 - Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers N/A
Completed NCT02484313 - The Effect of Snacks on Glycaemic Regulation in Children N/A
Withdrawn NCT01246492 - The Effect of Artificial Sweeteners on Blood Glucose Response N/A
Completed NCT01241253 - Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus Phase 2
Completed NCT03914430 - Breakfast Cereals Consumed in Dairy and Non-dairy Medium: the Effects on Blood Glucose, Satiety and Food Intake N/A
Recruiting NCT05255783 - The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients N/A
Completed NCT05573607 - Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life N/A
Recruiting NCT05585801 - Continuous Glucose Monitoring in Intensive Care Unit N/A